Clinical Trial Update: An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

View source ↗

Summary

An observational study completed to evaluate the safety and efficacy of pegfilgrastim (Neulasta) in female breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Kyowa Kirin Korea Co., Ltd. | Conditions: Breast Cancer Female, Breast Neoplasm Female | Status: COMPLETED